Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10



  Anika Therapeutics to Present at the Rodman & Renshaw Annual Global
  Investment Conference on September 10

               Presentation to be Webcast Live at 11:40 a.m. ET

Rodman & Renshaw Global Investment Conference 2013

Business Wire

BEDFORD, Mass. -- August 16, 2013

Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue
protection, healing and repair, based on hyaluronic acid (“HA”) technology,
today announced that its Chief Executive Officer, Charles Sherwood, Ph.D.,
will be presenting at the Rodman & Renshaw Annual Global Investment Conference
on Tuesday, September 10, 2013 at 11:40 a.m. ET. The conference is being held
at the Millennium Broadway Hotel in New York City.

An audio webcast of the presentation will be available live and may be
accessed via the “Investor Relations” section of Anika’s website at
www.anikatherapeutics.com. An archive of the presentation also will be
available on the website.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops,
manufactures and commercializes therapeutic products for tissue protection,
healing, and repair. These products are based on hyaluronic acid (HA), a
naturally occurring, biocompatible polymer found throughout the body. Anika’s
products range from orthopedic/joint health solutions led by Orthovisc^®, a
treatment for osteoarthritis of the knee; to surgical aids in the
anti-adhesion and ophthalmic fields. The company also offers aesthetic dermal
fillers for the correction of facial wrinkles. Anika’s Italian subsidiary,
Anika Therapeutics S.r.l., provides complementary HA products in
orthopedic/joint health and anti-adhesion, as well as therapeutics in areas
such as advanced wound treatment and ear, nose and throat care. Its
regenerative tissue technology advances Anika’s vision to offer therapeutic
products that go beyond pain relief to protect and restore damaged tissue.

Contact:

Anika Therapeutics, Inc.
Charles H. Sherwood, 781-457-9000
Ph.D., CEO
or
Sylvia Cheung, 781-457-9000
CFO
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement